Videos 41 - 50 for Tumour

10:50 -2 months ago
European Institute of Oncology, Milan, discusses her research into bacteria as agents to initiate potent anti-tumour activity. To view or download the slides click here ...
ecancermedicalscience.com    more  open  pop  

2 months ago
Group at the University of Dundee, where he leads a research team studying human tumour suppressor gene function. Speaking at AACR 2009: Reactivating mutant p53 genes, ...
ecancermedicalscience.com    more  open  pop  

10:33 -2 months ago
Oncopolicy Track Co-Chair Kathy Oliver (UK), Co-Director of the International Brain Tumour Alliance Maciej Krzakowksi (PL), The Maria Sklodowska-Curie Institute of Oncology ...
ecancermedicalscience.com    more  open  pop  

08:55 -2 months ago
New drug shrinks breast cancer tumours significantly in just six weeks research shows that cancer stem cells can be therapeutic target. ... Rodriguez.
ecancermedicalscience.com    more  open  pop  

05:37 -2 months ago
Prof Hans Jorg-Senn of the St Gallen Tumour Detection and Prevention Centre, Switzerland, talks to ecancer at IMPAKT 2009, about the role of IMPAKT, St Gallen 2009, and the ...
ecancermedicalscience.com    more  open  pop  

06:27 -2 months ago
Conference highlights and future of breast cancer care including freezing tumours and MRI scans for all. ... EBCC.
ecancermedicalscience.com    more  open  pop  

04:09 -2 months ago
, Sloan Kettering Memorial Cancer Center, US, talking to ecancer at AACR 2009 about Circulating tumour cells as biomarkers. Prostate cancer staging. Abiraterone acetate. ... tumour.
ecancermedicalscience.com    more  open  pop  

2 months ago
ECCO 15 - ESMO 34, Berlin 2009: Trials of two treatments for advanced melanoma show significant improvements in overall survival and rapid shrinking of tumours. PLX4032 ...
ecancermedicalscience.com    more  open  pop  

06:35 -2 months ago
standard treatment in patients with locally advanced rectal cancer does not improve tumour response. A preliminary analysis, however, suggests the treatment may reduce ...
ecancermedicalscience.com    more  open  pop  

07:37 -2 months ago
BRCA2 mutations and advanced breast cancer that persisted despite prior treatment experienced tumour shrinkage after receiving the investigational PARP inhibitor olaparib ...
ecancermedicalscience.com    more  open  pop